Synergy Pharmaceuticals TRULANCE(TM) (Plecanatide) Receives U.S. FDA Approval for the Treatment of Adults with Chronic Idiopathic Constipation
NEW YORK--(Healthcare Sales & Marketing Network)--Synergy Pharmaceuticals Inc. (SGYP) announced today that the U.S. Food and Drug Administration (FDA) has approved TRULANCE (plecanatide) for the treatment of adults with chronic idiopathic constipation (CI... Biopharmaceuticals, Gastroenterology, FDA Synergy Pharmaceuticals, TRULANCE, plecanatide, chronic idiopathic constipation
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Constipation | Food and Drug Administration (FDA) | Gastroenterology | Marketing | Pharmaceuticals